Evidence map›Paper›PMID 35312315›Full record

ReviewChemical research in toxicology2022

Triterpenoids as Reactive Oxygen Species Modulators of Cell Fate.

Taotao Ling, Lucinda Boyd, Fatima Rivas

Open access · hybridAbstract readReview
In one paragraph

Review in Chemical research in toxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Enteric-colonizedGut microbes · 2026
    Article
  2. Advances in Research onMolecules (Basel, Switzerland) · 2026
    Review
  3. Review
  4. Article
  5. Anti-Inflammatory Potential ofPharmaceuticals (Basel, Switzerland) · 2026
    Review
  6. Review
  7. Article
  8. Chios Mastic Gum Extract Enhances Antioxidant Defense in Zebrafish.International journal of molecular sciences · 2025
    Article
  9. Review
  10. Article
  11. Nutraceutical Potential of Bitter Melon (Current issues in molecular biology · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. F1000Research · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Taotao LingDepartment of Chemistry, Lousiana State University, 133 Chopping Hall, Baton Rouge, Louisiana 70803, United States.
Lucinda BoydDepartment of Chemistry, Lousiana State University, 133 Chopping Hall, Baton Rouge, Louisiana 70803, United States.
Fatima RivasDepartment of Chemistry, Lousiana State University, 133 Chopping Hall, Baton Rouge, Louisiana 70803, United States.ORCID 0000-0003-3643-2035

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The triterpenoid natural products have played an important role in understanding mechanistic models of human diseases. These natural products are diverse, but many have been characterized as reactive oxygen species (ROS) modulators. ROS can regulate cell survival and function, which ultimately affects biological processes leading to disease. The triterpenoids offer an untapped source of creativity to generate tool compounds with high selectivity to regulate ROS. This brief Review highlights the diverse complexity by which these secondary metabolites induce many cell death modalities (apoptosis, autophagy, ferroptosis, etc.) that can affect various complex cell signaling pathways through ROS and ultimately lead to evading or accelerating cell death.

Indexed as

Biological ProductsTriterpenesApoptosisAutophagyCell DeathHumansReactive Oxygen SpeciesBiological ProductsReactive Oxygen SpeciesTriterpenes

Identifiers

PMID35312315
PMCPMC9019815
OpenAlexW4220970715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.